EIF2AK3 and Alzheimer disease: Although further investigation is required for the demonstration of causal link, it is conceivable that PERK may be a crucial mediator of eIF2α phosphorylation responsible for pathogenic translational dysregulation under β-amyloidosis and thus represent a potential target for therapeutic interventions to treat AD.